These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 402175)

  • 61. Metabolism of acetylpolyamines by monoamine oxidase, diamine oxidase and polyamine oxidase.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y
    Biochim Biophys Acta; 1981 Oct; 677(2):190-3. PubMed ID: 6794648
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of diamine oxidase by 1,1-[(methylethanediylidene)-dinitrilo]-bis-(3-aminoguanidine) and 1,1'-[(methylethanediylidene)-dinitrilo]-diguanidine.
    Pegg AE; McGill SM
    Biochem Pharmacol; 1978; 27(12):1625-9. PubMed ID: 100119
    [No Abstract]   [Full Text] [Related]  

  • 63. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 64. Inhibitors of histamine metabolism in vitro and in vivo. Correlations with antitrypanosomal activity.
    Duch DS; Bacchi CJ; Edelstein MP; Nichol CA
    Biochem Pharmacol; 1984 May; 33(9):1547-53. PubMed ID: 6428421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of enzymes by metal ion-chelating reagents. The action of copper-chelating reagents on diamine oxidase.
    Bardsley WG; Childs RE; Crabbe MJ
    Biochem J; 1974 Jan; 137(1):61-6. PubMed ID: 4206911
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
    Braestrup C; Andersen H; Randrup A
    Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
    Celada P; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors.
    Boudíková-Girard B; Scott MC; Weinshilboum R
    Agents Actions; 1993 Sep; 40(1-2):1-10. PubMed ID: 8147263
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Active-site directed irreversible inhibition of diamine oxidase by a homologous series of aziridinylalkylamines.
    Conner JW; Yuan ZM; Callery PS
    Biochem Pharmacol; 1992 Sep; 44(6):1229-32. PubMed ID: 1417947
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro metabolism of putrescine by diamine oxidase in tissues of the pregnant rat.
    Andersson AC; Henningsson S
    Agents Actions; 1980 Apr; 10(1 Pt 2):104-6. PubMed ID: 6770610
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P; Youdim MB
    J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The kinetics of inhibition of type-B monoamine oxidase by clorgyline, pargyline and (-)-deprenyl.
    Green AL
    J Pharm Pharmacol; 1981 Dec; 33(12):798-800. PubMed ID: 6121857
    [No Abstract]   [Full Text] [Related]  

  • 76. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of enzyme inhibitors on histamine catabolism in man.
    LINDELL SE; NILSSON K; ROOS BE; WESTLING H
    Br J Pharmacol Chemother; 1960 Jun; 15(2):351-5. PubMed ID: 14417081
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hog kidney diamine oxidase conversion of biogenic diamines to inhibitors of cell proliferation.
    Gaugas JM; Dewey DL
    J Pathol; 1981 Jul; 134(3):243-52. PubMed ID: 6790686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diamine oxidase in relation to diamine and polyamine metabolism.
    Sessa A; Perin A
    Agents Actions; 1994 Nov; 43(1-2):69-77. PubMed ID: 7741045
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of plant and mammalian diamine oxidase by substrate analogues.
    Biegański T; Osińska Z; Masliński C
    Agents Actions; 1982 Apr; 12(1-2):41-6. PubMed ID: 6805264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.